These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 31789973)
1. Challenges and solutions to the study of rare childhood tumors. Fair D; Potter SL; Venkatramani R Curr Opin Pediatr; 2020 Feb; 32(1):7-12. PubMed ID: 31789973 [TBL] [Abstract][Full Text] [Related]
3. Rare pediatric tumors in Germany - not as rare as expected: a study based on data from the Bavarian Cancer Registry and the German Childhood Cancer Registry. Achajew A; Brecht IB; Radespiel-Tröger M; Meyer M; Metzler M; Bremensdorfer C; Spix C; Erdmann F; Schneider DT; Abele M Eur J Pediatr; 2022 Jul; 181(7):2723-2730. PubMed ID: 35478271 [TBL] [Abstract][Full Text] [Related]
4. Translational genomics for rare cancers: Challenges and opportunity. Tan AC; Huang PH Semin Cancer Biol; 2020 Apr; 61():iii-iv. PubMed ID: 32092353 [No Abstract] [Full Text] [Related]
5. Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group. Brecht IB; Graf N; Schweinitz Dv; Frühwald MC; Bielack SS; Schneider DT Klin Padiatr; 2009; 221(3):181-5. PubMed ID: 19437371 [TBL] [Abstract][Full Text] [Related]
6. Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010. Brecht IB; Bremensdorfer C; Schneider DT; Frühwald MC; Offenmüller S; Mertens R; Vorwerk P; Koscielniak E; Bielack SS; Benesch M; Hero B; Graf N; von Schweinitz D; Kaatsch P Pediatr Blood Cancer; 2014 Jul; 61(7):1202-9. PubMed ID: 24585499 [TBL] [Abstract][Full Text] [Related]
7. [Challenges for clinical research on rare tumors in Europe]. Blay JY Bull Acad Natl Med; 2013 Jan; 197(1):103-21; discussion 121-2. PubMed ID: 24672983 [TBL] [Abstract][Full Text] [Related]
8. Precision medicine in pediatric solid cancers. Blattner-Johnson M; Jones DTW; Pfaff E Semin Cancer Biol; 2022 Sep; 84():214-227. PubMed ID: 34116162 [TBL] [Abstract][Full Text] [Related]
9. Statistical genomics in rare cancer. Abbas-Aghababazadeh F; Mo Q; Fridley BL Semin Cancer Biol; 2020 Apr; 61():1-10. PubMed ID: 31437624 [TBL] [Abstract][Full Text] [Related]
10. Future of clinical genomics in pediatric oncology. Janeway KA; Place AE; Kieran MW; Harris MH J Clin Oncol; 2013 May; 31(15):1893-903. PubMed ID: 23589558 [TBL] [Abstract][Full Text] [Related]
11. Translating genomic discoveries to the clinic in pediatric oncology. Glade Bender J; Verma A; Schiffman JD Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895 [TBL] [Abstract][Full Text] [Related]
12. Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers. Groisberg R; Hong DS; Roszik J; Janku F; Tsimberidou AM; Javle M; Meric-Bernstam F; Subbiah V Mol Cancer Ther; 2018 Jul; 17(7):1595-1601. PubMed ID: 29654067 [TBL] [Abstract][Full Text] [Related]
13. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape. Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884 [TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
15. Rare childhood cancers--an increasing entity requiring the need for global consensus and collaboration. Kotecha RS; Kees UR; Cole CH; Gottardo NG Cancer Med; 2015 Jun; 4(6):819-24. PubMed ID: 25664881 [TBL] [Abstract][Full Text] [Related]
16. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A; Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376 [TBL] [Abstract][Full Text] [Related]
17. Clinical trial design for rare cancers: why a less conventional route may be required. Panageas KS Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109 [TBL] [Abstract][Full Text] [Related]
18. Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation. Mathoulin-Pélissier S; Pritchard-Jones K Eur J Surg Oncol; 2019 Jan; 45(1):22-30. PubMed ID: 29526369 [TBL] [Abstract][Full Text] [Related]
19. development of a therapeutic approach to rare cancers in children: the Children's Oncology Group experience. Pashankar FD; Rodriguez-Galindo C; Pappo A J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S37-8. PubMed ID: 22525404 [TBL] [Abstract][Full Text] [Related]
20. Advances and Challenges in Pediatric and Childhood Cancers. Hawkins C; Pfister S; Jones DTW; Shah NN; Gilbertson RJ; Sweet-Cordero EA; Dyer MA; Mossé YP; Haber M; DuBois SG Cancer Cell; 2020 Oct; 38(4):429-432. PubMed ID: 33049203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]